Here are six new shortages and discontinuations, according to drug supply databases from the FDA and the American Society of Health-System Pharmacists.
Supply Chain
A strike at U.S. East and Gulf Coast ports was averted Jan. 8 as dockworkers and employers reached a tentative labor agreement just days before the Jan. 15 deadline, The New York Times reported Jan. 8.
The FDA has released draft guidance for developers of AI-enabled medical devices, offering recommendations aimed at ensuring the safety and effectiveness of the devices.
The FDA is alerting healthcare providers about a potential high-risk issue with certain Baxter Healthcare Solution Sets with Duo-Vent Spikes.
UPS is shifting its focus from traditional parcel delivery to building a robust healthcare logistics business in an effort to offset slowing revenue from its core package services, Bloomberg reported Jan. 6.
Advertisement
Port workers represented by the International Longshoremen's Association are threatening to strike on Jan. 15, as contract negotiations with the United States Maritime Alliance, or USMX, remain stalled over issues of automation and job protections.
The FDA has issued an early warning regarding Medline Fluid Delivery Sets, which may pose a significant health risk due to a potentially incorrect assembly, according to a Dec. 30 news release from the agency.
McKesson Medical-Surgical will shut down its Rock Hill, S.C.-based distribution center in the spring, marking the end of its decade-long operation in the area, The Post and Courier reported Dec. 30.
Medline Industries confidentially filed a proposed initial public offering with the U.S. Securities and Exchange Commission.
Baxter has announced a significant milestone in its recovery efforts following Hurricane Helene, with eight of the 10 manufacturing lines at its North Cove site now restarted. This brings the site to approximately 85% of its pre-hurricane capacity.